« Back
Home /
SARS-CoV-2-IN-13

SARS-CoV-2-IN-13

Item no.	TMO-T60919-5mg
Manufacturer	TargetMol
CASRN	56961-10-5
Amount	5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Smiles	O=C(C1=CC(Cl)=CC=C1O)NC2=CC=C([N+]([O-])=O)C(Cl)=C2
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Short Description	SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide. SARS-CoV-2-IN-13 is more stable than niclosamide in human plasma and liver S9 enzymes assay. SARS-CoV-2-IN-13 can improve bioavailability and half-life when administered orally. SARS-CoV-2-IN-13 is a potent SARS-CoV-2 inhibitor with an IC 50 of 0.057 μM [1].
Shipping	cool pack
Storage	-20°
Molecular Weight	327, 12
Pathway	Microbiology/Virology
Target	SARS-CoV

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Delivery expected until 8/30/2024

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail